U.S. Approves New Drug to Prevent RSV in Babies, Toddlers
The U.S. Food and Drug Administration (FDA) on Monday approved a new drug to protect babies and toddlers from Respiratory Syncytial Virus (RSV). The...
Search
The Georgetown Post